Cargando…

Engineering CAR T cells for enhanced efficacy and safety

Despite its success in treating hematologic malignancies, chimeric antigen receptor (CAR) T cell therapy faces two major challenges which hinder its broader applications: the limited effectiveness against solid tumors and the nonspecific toxicities. To address these concerns, researchers have used s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yiqian, Huang, Ziliang, Harrison, Reed, Liu, Longwei, Zhu, Linshan, Situ, Yinglin, Wang, Yingxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AIP Publishing LLC 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769768/ https://www.ncbi.nlm.nih.gov/pubmed/35071966 http://dx.doi.org/10.1063/5.0073746

Ejemplares similares

Engineering light-controllable CAR T cells for cancer immunotherapy
por: Huang, Ziliang, et al.
Publicado: (2020)

Engineering inducible biomolecular assemblies for genome imaging and manipulation in living cells
por: Peng, Qin, et al.
Publicado: (2022)

Nano-Optogenetic Engineering of CAR T-cells for Precision Immunotherapy with Enhanced Safety
por: Nguyen, Nhung Thi, et al.
Publicado: (2021)

Integration of FRET and sequencing to engineer kinase biosensors from mammalian cell libraries
por: Liu, Longwei, et al.
Publicado: (2021)

Engineering CAR-T cells
por: Zhang, Cheng, et al.
Publicado: (2017)

Recent advances in CAR-T cell engineering
por: Huang, Ruihao, et al.
Publicado: (2020)

Engineering chimeric antigen receptor T cells for solid tumour therapy
por: Liu, Longwei, et al.
Publicado: (2022)

Engineering enhanced CAR T-cells for improved cancer therapy
por: Milone, Michael C., et al.
Publicado: (2021)

Overhauling CAR T Cells to Improve Efficacy, Safety and Cost
por: Chicaybam, Leonardo, et al.
Publicado: (2020)

Clinical Strategies for Enhancing the Efficacy of CAR T-Cell Therapy for Hematological Malignancies
por: Liu, Qianzhen, et al.
Publicado: (2022)

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
por: Arjomandnejad, Motahareh, et al.
Publicado: (2022)

Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
por: Chen, Qiuqiang, et al.
Publicado: (2022)

Engineering switchable and programmable universal CARs for CAR T therapy
por: Liu, Delong, et al.
Publicado: (2019)

LUNAS: A Rapid and Sensitive Nucleic Acid Detection Assay Using Split NanoLuc Luciferase Complementation
por: Liu, Longwei, et al.
Publicado: (2023)

NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness
por: Bachiller, Mireia, et al.
Publicado: (2021)

Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
por: Roex, Gils, et al.
Publicado: (2020)

Application of FRET Biosensors in Mechanobiology and Mechanopharmacological Screening
por: Liu, Longwei, et al.
Publicado: (2020)

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
por: Koristka, Stefanie, et al.
Publicado: (2019)

Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer
por: Henze, Janina, et al.
Publicado: (2020)

Conditioned CAR-T cells by hypoxia-inducible transcription amplification (HiTA) system significantly enhances systemic safety and retains antitumor efficacy
por: He, Huan, et al.
Publicado: (2021)

Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase
por: Durgin, Joseph S., et al.
Publicado: (2022)

Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL
por: Zhang, Jiqin, et al.
Publicado: (2022)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
por: Celichowski, Piotr, et al.
Publicado: (2023)

Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors
por: Kosti, Paris, et al.
Publicado: (2021)

Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas
por: Borchmann, Peter
Publicado: (2018)

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
por: Yeku, Oladapo O., et al.
Publicado: (2017)

Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
por: Li, Xin, et al.
Publicado: (2021)

Engineering CAR T Cells to Target the HIV Reservoir
por: Mu, Wenli, et al.
Publicado: (2020)

Combating challenges in CAR-T cells with engineering immunology
por: Wang, Clement Yisai, et al.
Publicado: (2022)

Cutting-Edge CAR Engineering: Beyond T Cells
por: Chocarro, Luisa, et al.
Publicado: (2022)

Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy
por: Chen, Huanpeng, et al.
Publicado: (2022)

Near-field engineering of Fano resonances in a plasmonic assembly for maximizing CARS enhancements
por: He, Jinna, et al.
Publicado: (2016)

Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies
por: Soldierer, Maren, et al.
Publicado: (2022)

New technologies of molecular engineering and screening for cell signaling studies
por: Wang, Yingxiao
Publicado: (2016)

An engineered CARS substrate with giant field enhancement in crisscross dimer nanostructure
por: Zhang, Jia, et al.
Publicado: (2018)

Monocytes engineered with iSNAP inhibit human B‐lymphoma progression
por: Wu, Haohsiang, et al.
Publicado: (2022)

speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing
por: Castellanos-Rueda, Rocío, et al.
Publicado: (2022)

Strategies to enhance CAR-T persistence
por: Liu, Yue, et al.
Publicado: (2022)

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
por: Maldonado-Pérez, Noelia, et al.
Publicado: (2022)

Reforming the Chimeric Antigen Receptor by Peptide Towards Optimized CAR T Cells With Enhanced Anti-Cancer Potency and Safety
por: Liu, Cuijuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7o4uojfa9fgu3nesvcrjg23ts9